Sickle Cell Anemia Drug Market Analysis - Global Industry Size, Share, Trends and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Forthcoming | Report ID : ARC571

Introduction

Sickle cell disease is an inherited group of syndrome in which RBCs twist to sickle shape. A cluster of syndromes causes red blood cells (RBCs) to become distorted and break down. Some of the common symptoms of sickle cell disease are pain, infection and fatigue. Popular treatments for this disease include rarely a bone-marrow transplant, blood transfusions and medication.

Market Dynamics

Growing geriatric population in major economies and rising healthcare spending and demand for drug therapy in combination with blood transfusion and surgeries are driving the market growth. In addition, overall cost of sickle cell disease diagnosis is reduced, which in turn, is majorly influencing the market growth. However, adverse effects from sickle cell anemia such as intravenous catheter associated infections, liver in-toxicity and low hemoglobin are impeding the growth of this market. Government emphasis on spreading awareness about sickle cell anemia cure combined with augmentation of FDA approved drug accessibility are propelling the market expansion over the forecast period.

 Market Classification

The sickle cell anemia drug market is segmented on the basis of mode of delivery, end-user and geography. Based on mode of delivery, the market is classified into oral and injection. Based on type, the market is classified into hospital, clinic and others. Based on geography, market is divided into North America, Latin America, Europe, Asia-Pacific and Middle East & Africa (MEA).

Report Coverage

Market

Sickle Cell Anemia Drug Market

Analysis Period

2015 – 2026

Historic Data

2015 – 2016

Base Year

2017

Forecast Data

2018 – 2026

Market Stratification

Mode of Delivery, End-User, Geography

Regional Scope

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)

Report Coverage

Market Trends, Drivers, Restraints, Porter's Five Forces Analysis, Competitive Analysis,

Player Profiling, Value Chain Analysis

 

Market Participants

The market players in the sickle cell anemia drug market include Alnylam Pharmaceuticals, Inc., Pfizer Inc., Eli Lilly and Company, Baxter International Inc., Emmaus Life Sciences, Inc., Novartis AG, AstraZeneca Plc., Sangamo Therapeutics, Inc., bluebird bio, Inc., Global Blood Therapeutics Inc., Bristol-Myers Squibb Company, Acceleron Pharma, Inc. and Arena Pharmaceuticals, Inc. among others.

Market Segmentation

Market By Mode of Delivery

·         Oral

·         Injection

Market By End-Users

·         Hospital

·         Clinic

·         Others

Market By Geography

·         North America

o   US

o   Canada

o   Mexico

·         Europe

o   UK

o   Germany

o   France

o   Rest of Europe

·         Asia-Pacific

o   China

o   Japan

o   India

o   Australia

o   Rest of Asia-Pacific

·         Latin America

o   Brazil

o   Rest of Latin America

·         Middle East and Africa (MEA)

o   South Africa

o   Saudi Arabia

o   Rest of MEA


Related Reports

Biomedical Refrigerators and Freezers Market (By Product: Plasma Freezers, Blood Bank Refrigerators, Lab Refrigerators, Lab Freezers, Ultra-low Temperature Freezers, Shock Freezers; By End-use: Blood Banks, Pharmacies, Hospitals, Research Labs, Diagnostic Centers) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction Biomedical freezers and refrigerators are medicinal devices that are specially used to store up various medical samples such as vaccines, blood products, medicines, flammable chemicals and enzymes. Biomedical freezers and refrigerators are used in research laboratories, hospitals, pharmacies, diagnostic centers, and blood banks. Biomedical freezers and refrigerators offer optimal storage of me

Point of Care Testing Market (By Product: Glucose monitoring [Strips, Meters, Lancets], Cardiometabolic testing products [Cardiac marker testing products, Blood Gas/Electrolytes testing products, HBA1C testing products], Infectious disease testing products [Influenza testing products, HIV testing products, Hepatitis C testing products, Sexually Transmitted Disease (STD) testing products, Healthcare-Associated Infection (HAI) testing products, Respiratory infection testing products, Tropical disease testing products, Other infectious diseases testing products], Coagulation testing products [PT/INR testing products, Activated Clotting Time (ACT/APTT) testing products], Pregnancy and fertility testing products [Pregnancy testing products, Fertility testing products], Tumor/Cancer marker testing products, Urinalysis testing products, Cholesterol testing products, Hematology testing products, Drug-of-Abuse (DoA) testing products, Fecal occult testing products, Other products; By Technology: Lateral flow assays, Dipsticks, Microfluidics, Molecular diagnostics, Immunoassays, Agglutination assays, Flow-Through, Solid phase, Biosensors; By Prescription: OTC testing, Prescription-based testing; By Application: Cardio metabolic testing, Infectious disease testing, Nephrology testing, Drug-of-Abuse (DoA) testing, Blood glucose testing, Pregnancy testing, Cancer biomarker testing, Other applications; By End-user: Hospitals, Diagnostic centers, Research laboratories, Home-care settings, Other end-uses) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction Global point of care testing market is expected develop at a CAGR of over 7.4% throughout the forthcoming years and industry is worth at over USD 21.7 billion in 2018 and is likely to rise up to USD 38.40 billion by 2026. Market Dynamics Increment in number of in

Oncology Information Systems Market (By Products & Services: Software [Patient Information Systems, Treatment Planning Systems], Professional Services; By Application: Medical Oncology, Surgical Oncology, Radiation Oncology) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction Oncology Information Systems is well known for managing portfolios by software across healthcare settings, such as hospitals, research laboratories, and clinics. In addition, this software is useful to envisage treatment outcomes; accordingly, this software helps to plan the patient’s treatment, and also provide information about cancer patient among overall heal

Image-Guided & Robot-Assisted Surgical Procedures Market (By Specialty Type: Gynecologic Surgery, Urologic Surgery, General Surgery, Cardiothoracic Surgery, Head & Neck Specialties) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The global Image-guided & robot-assisted surgical procedures market size is anticipated to around USD 6.0 billion by 2026, this market is anticipated to grow with 14.9% CAGR during the forecast time period. Market Dynamics Speedy technological progressions in

Home Healthcare Market (By Component: Equipment [Therapeutic, Diagnostic, Mobility assist], Services [Rehabilitation, Unskilled home care, Respiratory therapy services, Infusion therapy services, Telemetry) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The global home healthcare market size is anticipated to around USD 528.2 billion by 2026, this market is anticipated to grow with 7.9% CAGR during the forecast time period. Need for home healthcare services is increasing inferable from advantages, for example, enhanced patient result, long term care, cost proficiency, end of superfluous hospitalizatio

Cart Summary